With a prevalence of approximately 2–3 per 1000 livebirths, cerebral palsy (CP) is one of the most common physical and developmental disabilities in childhood. CP is caused by a non-progressive lesion in the developing brain during the prenatal, perinatal or postnatal periods, and presents lifelong and heterogeneous neurological conditions. An acknowledge consensus definition from 2006, describes CP as ‘a group of permanent disorders of the development of movement and posture, causing activity limitation.

How MEDESTO can help a children with cerebral palsy?

Our first goal is improve the standard of Life (QOL) of youngsters with CP!

While there's no cure for brain disorder, the QOL will improve with skilled medical aid mistreatment specialized device. The MEDESTO Glove is a superb upper limb coaching device which will be utilized by youngsters and adolescents for a large style of medical aid coaching.

A daily program of exercise with the MEDESTO Glove reception will fill a crucial role in up the QOL. The continued  use of the MEDESTO Glove will embrace the following:

  • Improve Motor Coordination

  • Reduce Spasms

  • Better Balance and walking management​

Proffered training modes using MEDESTO Glove:

Passive flexion and extension of fingers to reduce spasticity
Improve fine motor skills using "Single Finger mode training"
Grasp objects like the MEDESTO small balls or the children's ​toys

Mirror Therapy mode to improve neuroplasticity of the brain



Early signs of CP usually emerge before the first or second year of life, when infants fail to reach key milestones at the expected age. Through childhood, the clinical features of neuromotor impairments become more remarkable and variable in types and severity. The manifestations of CP chiefly include abnormalities of muscle tone and reflexes, impaired selective motor control, lack of coordination, atypical posture and movement patterns and delayed gross and fine motor development. In addition, CP is often accompanied by comorbidities and secondary problems, such as visual and hearing deficits, intellectual disabilities, epilepsy, contracture and deformities.

Besides symptoms, CP can be displayed within the International Classification of Functioning, Disability and Health (ICF) and the derived version for Children and Youth (ICF-CY) (WHO). Several studies have reported that children and adolescents with CP exhibit various impairments in body function and structure, and have difficulties performing a wide range of activities.10 11 The limitations in everyday functioning are common in mobility, self-care, play, school and physical activities. Moreover, children and adolescents with CP engage poorly in social and leisure activities comparing to normally developing peers. These limitations and restrictions interrelate to a number of contextual factors, which may facilitate or hinder individuals with CP to be more or less independent living and health outcomes.

The management of CP requires a multidisciplinary, holistic and long-term care approaches, involving medical and pharmacological treatments, rehabilitation interventions and assistive technologies alongside complementary and alternative remedies. In the 21st century, advanced rehabilitation technologies are more available to patients with neurological conditions, in particular therapeutic robots. Robotic devices have been widely integrated into clinicians’ service in order to mediate and assist interventions to enhance clients’ recovery and clinical outcomes resulting from stroke, traumatic brain injury, multiple sclerosis, spinal cord injury and other congenital and acquired movement disorders.

There is a growing need of robotic-assisted therapy in the pediatric field and care delivery for children and adolescents with CP. Based on the applying principles of neural plasticity, motor control and motor learning, robotic rehabilitation premises in the adaptability of the brain, which may occur spontaneously over time and/or be induced by movement practice after lesion. Thus, the implementation of robotics primarily focuses on functional motor performance by providing intensive repetitive training, sensorimotor integration and cognitive engagement through goal-directed tasks to address the underlying symptoms and related problems due to client’s neurological conditions. From previous studies, the use of robotic devices has been found to improve kinematics, range of motion, muscle tone postural control and functionality of upper and lower extremities among individuals with CP.

​The Active Passive mode using MEDESTO Glove may be a family of distinctive exercise rehabilitation trainers for upper limbs. The MEDESTO Glove offers advantages that rehabilitation professionals expect from a medical device that's quality built and government agency and Ce registered. The MEDESTO Glove is usually employed in physical therapy clinics within the USA and round the world and over the years multiple clinical studies have confirmed the advantages of the trainer.

For upper extremity motor performance, there is evidence that up to 80% of CP clients have upper limb involvement and demonstrate limited functions. In general, the acquisition of efficient arm and hand skills for use in daily life is a complex process that not only requires neuromusculoskeletal integrity, but also involves various aspects of a child’s capabilities. Therefore, apart from positive symptoms that typically present patterns of spasticity, children and adolescents with CP often have a poor ability to reach, grasp, release and manipulate objects. Furthermore, they experience difficulty using their upper extremities to perform self-care and other activities. These problems present great challenges in management and provision of therapeutic intervention, and even in the development and application of innovative technologies such as robotic devices.

To date, varying interventions are recommended to ameliorate movements and activities in upper extremity for CP clients, for example constraint-induced movement therapy, hand-arm bimanual intensive therapy, neurodevelopmental therapy, intramuscular injection of botulinum neurotoxin A, as well as, robotic-assisted therapy. Current robotic devices for upper extremity rehabilitation are undid on two main designs. First, an end-effector is a robotic device in which movements are generated from the contact point in the most distal part of the extremity. Second, as a wearable robotic device, an exoskeleton attaches to multiple joints that can reproduce movements in the corresponding parts of the extremity at the same time.


486 081 05801